International Journal of In-Silico Drug Design (IJISDD)
The International Journal of In-Silico Drug Design serves as a platform for research papers that are important to all fields of fundamental science and therapeutics. These articles are published at the intersection of computing, pharmacology, toxicology, and pharmaceutics at the same time. Within the framework of this discussion, the journal has a particular interest in the fields of neuroscience, drug discovery and development, as well as state-of-the-art multiscale modeling, informatics, artificial intelligence, and big data. Within the scope of In Silico Pharmacology, it is predicted that all computational and experimental methods will be included. Without experimental validation, papers are required to incorporate a significant amount of computational material.
Interdisciplinary studies that address computational techniques in drug design and multi-scale analysis of bioactive substances from the cellular level all the way up to the behavioral level that are published in the journal are the primary focus of the publication. In Silico Pharmacology, a particular emphasis is placed on the encouragement of deterministic and stochastic modeling of biological processes that lead to therapeutic advancements. These processes include biochemical, biophysical, and immunological processes. Additionally, mathematical methods that characterize the pharmacology of substances within living organisms are also encouraged there. Additionally, we would like to encourage papers that investigate the morphological and genetic changes that are generated by substances or materials. Manuscripts regarding research proposals and research ideas will be particularly welcomed computed data or files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material we also accept manuscripts communicating to a broader audience about research projects financed with public funds.
Our values
We are unwavering
in our mission and
act with urgency to make all science openly available. We know that immediate,
free access to high-quality research is vital for achieving this. With open-access publishing, knowledge is being shared immediately, without restrictions,
enabling researchers to collaborate better and innovate faster to solve the
critical challenges we face as humanity.
That's why every decision we make starts with one consideration: what’s best for the researcher – the people doing the science? Our role is to provide the world’s scientists with the best, the fastest, and the most efficient publishing experience. This approach forms the basis of our core values, which we believe are crucial to achieving our mission.
Our commitment
At IJISDD, the founders, investors, staff, and editorial boards all have a long-term aim to make all of science accessible to the public. This is the ethos that drives the organization. The ultimate goal is to make it possible for society to develop knowledge more expediently and effectively, which will eventually speed up innovation, health, and prosperity for everyone. The complete adoption of open access as the standard approach for publishing research findings that have been subjected to quality control will serve as the primary indicator of success. Together, we are sure that we will be able to make the future of science completely accessible and expedite the answers that we require in order to live healthy lives on a healthy planet. This confidence is a direct result of the tireless efforts of the devoted individuals who work at IJISDD, as well as the engagement of our research communities.
Further Insights
In-vitro In-vivo Original study, Reviews, Literature Review, Conference proceedings, Case studies, Short communication, Thesis, Letters to the editor, and Editorials covered theoretical and methodological study are accepted by In-silico Journal. Similar to "in vivo" and "in vitro" biological research, "in silico" denotes the expansion of observations via computer-based simulations and model inquiries.
The journal invites scientists, pharmaceutical firms, regulators, and other stakeholders interested in treating, preventing, and detecting illnesses to share cutting-edge research and updates. IIIJ facilitates open discussions and debates on drug discovery breakthroughs. The journal publishes animal research, toxicity evaluation, pharmacological and toxicological testing, and pharmacokinetic-pharmacodynamic modeling of novel drug candidates.
IIIJ accepts global research submissions. Submissions should aim to create and optimize innovative treatments and medications and examine drug development rules, clinical effects, and ethics. An open-access platform will speed research and bring us closer to life-threatening illness treatments.
Some Tags: Artificial fertilization, Ovarian polycyst, Implantation, Treatment with IVF, Designing experiments, Medical Precision, Pharmacogenomics, Histopathology, Pharmaceutics, Medicinal Chemistry, Food chemistry, Genotoxicity, Frozen embryo transfer, Pharmacognosy, Nuclear Pharmacy, Inhibiting Enzymes, Induction of ovulation, Intrafallopian gamete transfer, Antimicrobials, Assisted hatching, Cheminformatics, Surgery for fertility, Computational analysis, ART (assisted reproduction), Stage embryo cleavage, Single embryo transfer, Pharmacology network, Damaged and repaired DNA, Karyomapping, Testing in vitro, Animal models in vivo, Biological system computational modeling, Drug discovery insilico, Pharmacokinetic/pharmacodynamic modeling, Invitro toxicology screening, Molecular docking models, Insilico protein structure prediction, Molecular modeling drug design, Gene expression analysis in vitro, Insilico natural compound screening, Simulations of clinical trials, Computer models predict drug metabolism, Cancer models in vitro, Imaging in vivo, Virtual insilico screening, The quantitative structure-activity connection model, On-chip organs in vitro, Electrophysiology in vivo, In-silico network analysis, Modeling pharmacophore, Discovery of biomarkers in vitro, Vivo physiology measures, Systems biology insilico, Simulations of protein-ligand interactions, Stem cell cultivation in vitro, In-vivo immunology tests, Insilico high-throughput screening, Drug modeling using quantitative systems, Microfluidics in vitro, In-vivo optogenetics, INSILCO molecular dynamics simulations, In vitro genome-wide association studies, Interactive protein-protein analysis insilico, Bioassays for drug development in vitro, Pharmacology in vivo, Insilico transcriptomics, Studying drug metabolism in vitro, Neuroscience in vivo, Insilico route analysis, Invitro high-content screening, Behavioral in vivo tests, Bioinformatics insilico, Epigenetic in vitro studies, Insilico homology models, Live cardiac physiology measures, Multi-omics in vitro, A insilico evolutionary biology study, Studies of circadian rhythm in vivo, Insilico metabolic pathway analysis.
Some keywords were not limited to the journal's scope. For questions, email info@openaccesspub.org.
The journal invites scientists, pharmaceutical firms, regulators, and other stakeholders interested in treating, preventing, and detecting illnesses to share cutting-edge research and updates. IIIJ facilitates open discussions and debates on drug discovery breakthroughs. The journal publishes animal research, toxicity evaluation, pharmacological and toxicological testing, and pharmacokinetic-pharmacodynamic modeling of novel drug candidates.
IIIJ accepts global research submissions. Submissions should aim to create and optimize innovative treatments and medications and examine drug development rules, clinical effects, and ethics. An open-access platform will speed research and bring us closer to life-threatening illness treatments.
Some Tags: Artificial fertilization, Ovarian polycyst, Implantation, Treatment with IVF, Designing experiments, Medical Precision, Pharmacogenomics, Histopathology, Pharmaceutics, Medicinal Chemistry, Food chemistry, Genotoxicity, Frozen embryo transfer, Pharmacognosy, Nuclear Pharmacy, Inhibiting Enzymes, Induction of ovulation, Intrafallopian gamete transfer, Antimicrobials, Assisted hatching, Cheminformatics, Surgery for fertility, Computational analysis, ART (assisted reproduction), Stage embryo cleavage, Single embryo transfer, Pharmacology network, Damaged and repaired DNA, Karyomapping, Testing in vitro, Animal models in vivo, Biological system computational modeling, Drug discovery insilico, Pharmacokinetic/pharmacodynamic modeling, Invitro toxicology screening, Molecular docking models, Insilico protein structure prediction, Molecular modeling drug design, Gene expression analysis in vitro, Insilico natural compound screening, Simulations of clinical trials, Computer models predict drug metabolism, Cancer models in vitro, Imaging in vivo, Virtual insilico screening, The quantitative structure-activity connection model, On-chip organs in vitro, Electrophysiology in vivo, In-silico network analysis, Modeling pharmacophore, Discovery of biomarkers in vitro, Vivo physiology measures, Systems biology insilico, Simulations of protein-ligand interactions, Stem cell cultivation in vitro, In-vivo immunology tests, Insilico high-throughput screening, Drug modeling using quantitative systems, Microfluidics in vitro, In-vivo optogenetics, INSILCO molecular dynamics simulations, In vitro genome-wide association studies, Interactive protein-protein analysis insilico, Bioassays for drug development in vitro, Pharmacology in vivo, Insilico transcriptomics, Studying drug metabolism in vitro, Neuroscience in vivo, Insilico route analysis, Invitro high-content screening, Behavioral in vivo tests, Bioinformatics insilico, Epigenetic in vitro studies, Insilico homology models, Live cardiac physiology measures, Multi-omics in vitro, A insilico evolutionary biology study, Studies of circadian rhythm in vivo, Insilico metabolic pathway analysis.
Some keywords were not limited to the journal's scope. For questions, email info@openaccesspub.org.
0 Comments